Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-02-26 @ 2:16 AM
Study NCT ID:
NCT02658968
Status:
COMPLETED
Last Update Posted:
2024-01-16
First Post:
2015-12-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
Sponsor:
Nordic Nanovector
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-22
First Submit QC Date:
None
Study First Post Date:
2016-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-05-09
Results First Submit QC Date:
None
Results First Post Date:
2024-01-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-12
Last Update Post Date:
2024-01-16
Last Update Post Date Type:
ACTUAL